Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a letter
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need Help? E-mail the JCI
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI117417

Identification of a novel first exon in the human dystrophin gene and of a new promoter located more than 500 kb upstream of the nearest known promoter.

H Nishio, Y Takeshima, N Narita, H Yanagawa, Y Suzuki, Y Ishikawa, Y Ishikawa, R Minami, H Nakamura, and M Matsuo

Department of Pediatrics, Kobe University School of Medicine, Japan.

Find articles by Nishio, H. in: JCI | PubMed | Google Scholar

Department of Pediatrics, Kobe University School of Medicine, Japan.

Find articles by Takeshima, Y. in: JCI | PubMed | Google Scholar

Department of Pediatrics, Kobe University School of Medicine, Japan.

Find articles by Narita, N. in: JCI | PubMed | Google Scholar

Department of Pediatrics, Kobe University School of Medicine, Japan.

Find articles by Yanagawa, H. in: JCI | PubMed | Google Scholar

Department of Pediatrics, Kobe University School of Medicine, Japan.

Find articles by Suzuki, Y. in: JCI | PubMed | Google Scholar

Department of Pediatrics, Kobe University School of Medicine, Japan.

Find articles by Ishikawa, Y. in: JCI | PubMed | Google Scholar

Department of Pediatrics, Kobe University School of Medicine, Japan.

Find articles by Ishikawa, Y. in: JCI | PubMed | Google Scholar

Department of Pediatrics, Kobe University School of Medicine, Japan.

Find articles by Minami, R. in: JCI | PubMed | Google Scholar

Department of Pediatrics, Kobe University School of Medicine, Japan.

Find articles by Nakamura, H. in: JCI | PubMed | Google Scholar

Department of Pediatrics, Kobe University School of Medicine, Japan.

Find articles by Matsuo, M. in: JCI | PubMed | Google Scholar

Published September 1, 1994 - More info

Published in Volume 94, Issue 3 on September 1, 1994
J Clin Invest. 1994;94(3):1037–1042. https://doi.org/10.1172/JCI117417.
© 1994 The American Society for Clinical Investigation
Published September 1, 1994 - Version history
View PDF
Abstract

The dystrophin gene, which is mutated in patients with Duchenne and Becker muscular dystrophies, is the largest known human gene. Five alternative promoters have been characterized until now. Here we show that a novel dystrophin isoform with a different first exon can be produced through transcription initiation at a previously unidentified alternative promoter. The case study presented is that of a patient with Duchenne muscular dystrophy who had a deletion extending from the 5' end of the dystrophin gene to exon 2, including all promoters previously mapped in the 5' part of the gene. Transcripts from lymphoblastoid cells were found to contain sequences corresponding to exon 3, indicating the presence of new promoter upstream of this exon. The nucleotide sequence of amplified cDNA corresponding to the 5' end of the new transcript indicated that the 5' end of exon 3 was extended by 9 codons, only the last (most 3') of which codes for methionine. The genomic nucleotide sequence upstream from the new exon, as determined using inverse polymerase chain reaction, revealed the presence of sequences similar to a TATA box, an octamer motif and an MEF-2 element. The identified promoter/exon did not map to intron 2, as might have been expected, but to a position more than 500 kb upstream of the most 5' of the previously identified promoters, thereby adding 500 kb to the dystrophin gene. The sequence of part of the new promoter region is very similar to that of certain medium reiteration frequency repetitive sequences. These findings may help us understand the molecular evolution of the dystrophin gene.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1037
page 1037
icon of scanned page 1038
page 1038
icon of scanned page 1039
page 1039
icon of scanned page 1040
page 1040
icon of scanned page 1041
page 1041
icon of scanned page 1042
page 1042
Version history
  • Version 1 (September 1, 1994): No description

Article tools

  • View PDF
  • Download citation information
  • Send a letter
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need Help? E-mail the JCI

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts